Response to ‘Re: Kakkos et al. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials’

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of vascular and endovascular surgery 2015-03, Vol.49 (3), p.353-354
Hauptverfasser:	Kakkos, S.K, Kirkilesis, G.I, Tsolakis, I.A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - therapeutic use Benzimidazoles - therapeutic use beta-Alanine - analogs & derivatives Humans Morpholines - therapeutic use Pyrazoles - therapeutic use Pyridines - therapeutic use Pyridones - therapeutic use Secondary Prevention Surgery Thiazoles - therapeutic use Thiophenes - therapeutic use Venous Thromboembolism - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!